(Q48550046)

English

WAY 100635, a 5-HT1A receptor antagonist, prevents the impairment of spatial learning caused by intrahippocampal administration of scopolamine or 7-chloro-kynurenic acid.

scientific article published in November 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/9452205

WAY 100635, a 5-HT1A receptor antagonist, prevents the impairment of spatial learning caused by intrahippocampal administration of scopolamine or 7-chloro-kynurenic acid. (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/9452205

1 reference

based on heuristic

inferred from title

author name string

Carli M

1

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/9452205

Bonalumi P

2

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/9452205

Samanin R

3

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/9452205

language of work or name

0 references

publication date

1 November 1997

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/9452205

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/9452205

774

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/9452205

1-2

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/9452205

167-174

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/9452205

Novel anxiolytics discriminate between postsynaptic serotonin receptors mediating different physiological responses on single neurons of the rat hippocampus.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2981700-3

7 January 2021

Effects of 5-HT1A receptor antagonists on hippocampal 5-hydroxytryptamine levels: (S)-WAY100135, but not WAY100635, has partial agonist properties

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2981700-3

7 January 2021

Acetylcholine induced modulation of hippocampal pyramidal neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2981700-3

7 January 2021

Stimulation of 5-HT1A receptors in the dorsal hippocampus impairs acquisition and performance of a spatial task in a water maze

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2981700-3

7 January 2021

(S)-WAY 100135, a 5-HT1A receptor antagonist, prevents the impairment of spatial learning caused by intrahippocampal scopolamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2981700-3

7 January 2021

Dose-related impairment of spatial learning by intrahippocampal scopolamine: antagonism by ondansetron, a 5-HT3 receptor antagonist.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2981700-3

7 January 2021

Pharmacological and functional analysis of a novel serotonin receptor in the rat hippocampus.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2981700-3

7 January 2021

Differential modulation of three separate K-conductances in hippocampal CA1 neurons by serotonin

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2981700-3

7 January 2021

A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2981700-3

7 January 2021

Cortical pyramidal neurone loss may cause glutamatergic hypoactivity and cognitive impairment in Alzheimer's disease: investigative and therapeutic perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2981700-3

7 January 2021

Density and distribution of NMDA receptors in the human hippocampus in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2981700-3

7 January 2021

Hippocampal serotonin 5-HT1A receptor enhances acetylcholine release in conscious rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2981700-3

7 January 2021

Pharmacological and immunohistochemical evidence for serotonergic modulation of cholinergic nucleus basalis neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2981700-3

7 January 2021

Preservation of hippocampal NMDA receptors may be crucial for spatial learning after epileptic seizures in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2981700-3

7 January 2021

Place navigation impaired in rats with hippocampal lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2981700-3

7 January 2021

Intrahippocampal administration of a glycine site antagonist impairs working memory performance of rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2981700-3

7 January 2021

Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2981700-3

7 January 2021

Reduced glycine stimulation of [3H]MK-801 binding in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2981700-3

7 January 2021

Combined treatment with a 5HT1A receptor agonist and a muscarinic acetylcholine receptor antagonist disrupts water maze navigation behavior.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2981700-3

7 January 2021

Multiple actions of acetylcholine at a muscarinic receptor studied in the rat hippocampal slice

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2981700-3

7 January 2021

Serotonin reduces synaptic excitation of principal cells in the superficial layers of rat hippocampal-entorhinal cortex combined slices

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2981700-3

7 January 2021

A post-synaptic depressant modulatory action of 5-hydroxytryptamine on excitatory amino acid responses in rat entorhinal cortex in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2981700-3

7 January 2021

Involvement of glycine site associated with the NMDA receptor in hippocampal long-term potentiation and acquisition of spatial memory in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2981700-3

7 January 2021

Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2981700-3

7 January 2021

Postsynaptic localization of muscarinic cholinergic receptor binding in rat hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2981700-3

7 January 2021

Human amnesia and the medial temporal region: enduring memory impairment following a bilateral lesion limited to field CA1 of the hippocampus

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2981700-3

7 January 2021

Identifiers

10.1016/S0006-8993(97)81700-3

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/9452205

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 February 2018

http://europepmc.org/abstract/MED/9452205

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48550046&oldid=2120505238"